MedPath

Sulfacetamide

Generic Name
Sulfacetamide
Brand Names
Avar, Blephamide, Cetamide, FML-S, Isopto Cetamide, Klaron, Ovace, Plexion, Sulf-10, Sumadan Wash, Sumaxin
Drug Type
Small Molecule
Chemical Formula
C8H10N2O3S
CAS Number
144-80-9
Unique Ingredient Identifier
4965G3J0F5

Overview

An anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections.

Indication

For the treatment of bacterial vaginitis, keratitis, acute conjunctivitis, and blepharitis.

Associated Conditions

  • Acne Vulgaris
  • Conjunctivitis
  • Trachoma
  • Superficial ocular infections

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2014/10/06
Phase 4
Completed
Joseph B. Ciolino, MD

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Gabar Health Sciences Corp.
82429-107
TOPICAL
10 mg in 1 g
10/21/2023
Eckson Labs LLC
44118-701
TOPICAL
98 mg in 1 g
3/30/2022
Keltman Pharmaceuticals Inc.
68387-491
OPHTHALMIC
100 mg in 1 mL
7/12/2010
Brava Pharmaceuticals, LLC
57883-404
TOPICAL
98 mg in 1 g
12/26/2019
BioComp Pharma, Inc.
44523-520
TOPICAL
100 mg in 1 g
8/16/2023
BioComp Pharma, Inc.
44523-602
TOPICAL
100 mg in 1 g
3/23/2023
Acella Pharmaceuticals, LLC
42192-133
TOPICAL
80 mg in 1 mL
9/11/2018
Sandoz Inc.
61314-701
OPHTHALMIC
100 mg in 1 mL
8/5/2011
KMM Pharmaceuticals, LLC
52187-553
TOPICAL
98 mg in 1 mL
2/14/2022
Eckson Labs, LLC
44118-712
TOPICAL
98 mg in 1 mL
2/10/2022

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
VASOSULF OPH SOLN
iolab pharmaceuticals
00760048
Drops - Ophthalmic
150 MG / ML
12/31/1988
PREDNISOLONE/SULFACETAMIDE
pharma stulln inc.
02023814
Suspension - Ophthalmic
10 % / W/V
12/31/1994
CETAMIDE ONT 10%
Alcon Canada Inc
00252522
Ointment - Ophthalmic
10 %
12/31/1972
VASOCIDIN OPHTHALMIC SOLUTION
iolab pharmaceuticals
00843741
Liquid - Ophthalmic
100 MG / ML
12/31/1992
VASOCIDIN OPHTHALMIC SOLUTION
novartis ophthalmics novartis pharmaceuticals (canada) inc
02133342
Solution - Ophthalmic
100 MG / ML
12/31/1996
BLEPHAMIDE S.O.P.
00307246
Ointment - Ophthalmic
10 %
12/31/1974
SULFEX 10%
laboratoires charton laboratories
00554022
Liquid - Ophthalmic
10 %
12/31/1982
ODAN-SULFACETAMIDE
odan laboratories ltd
00622966
Solution - Ophthalmic
10 %
12/31/1985
METIMYD OPH SUS
schering-plough canada inc
00177024
Suspension - Ophthalmic
100 MG / ML
12/31/1956
SODIUM SULAMYD OPH DPS 30%
schering-plough canada inc
00028061
Drops - Ophthalmic
300 MG / ML
12/31/1951

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.